Home Technology Medical device Global Medical Device Contract...
Medical Device
CIO Bulletin
24 February, 2025
The market will expand to $216.41 billion by 2034 because technology development combined with sustainability considerations along with increased healthcare needs.
The medical device contract manufacturing market achieved significant expansion in 2023 as data showed a $73.61 billion value that is projected to grow to $81.19 billion during 2024. A 10.3% growth rate between 2025 and 2034 will propel the market value to $216.41 billion.
The market experiences growing demand because healthcare requirements rise while technology develops and manufacturers choose outsourcing as a preference. Healthcare device companies rely on contract manufacturers to fulfill two main operational requirements as they seek more affordable production and maintain strict regulatory compliance.
The market includes four primary segments namely diagnostic devices combined with therapeutic equipment joined by surgical instruments together with patient monitoring systems. Medical device companies leverage contract manufacturing services which offer complete assistance from product development to regulatory compliance maintenance thereby allowing companies to expand manufacturing operations at high quality levels.
In fact, 3D printing, artificial intelligence-powered analytics, and robotic-enabled automation are examples of the rapidly evolving technological advancements that are likely to reshape this specific industry. The innovations enhance manufacturing efficiency and lower human mistakes and enable accelerated delivery of accurately designed medical equipment.
The medical industry witnesses rising demand for environmentally responsible production techniques along with sustainable materials because sustainability has become a primary industry trend.
The medical device contract manufacturing market has excellent expansion potential because of technological advancements alongside sustainability commitments and customer preferences for patient-specific healthcare devices.
Insurance and capital markets







